I2F® — Protecting Medications. Reducing Waste. Saving Time.
I2F Quick Start
Watch a Demo • Calculate ROI • Schedule a Call
WHAT IS I2F?
I2F is a patented device for injectables and infusions that eliminates trapped air during medication withdrawal, helping reduce overpressure spray, foaming, and protein agitation.
Protects Medications
Helps stabilize sensitive biologics by minimizing air exposure and agitation.
Reduces Hidden Waste
Prevents invisible dose loss caused by vial overpressure and spray.
Saves Prep Time
Streamlines medication access and reduces workflow interruptions.
I2F® — powered by Aeristasis™ Technology
Controlled air equilibrium for predictable medication access
Patented technology • Single-use device • Designed for clinical workflows
How it works
See how I2F creates controlled air equilibrium to support cleaner, more predictable medication access.
Want to review this later?
We’ll open your email app so you can send this page to yourself.
Calculate Your Potential ROI
Enter a few details below to estimate potential medication waste reduction.
Calculate Your Lost Revenue
Enter the number of vials you use per month.
Show More Medications
Email me my results
White Papers & Clinical Insights
Explore our published and in-progress research on medication stability, dose loss, and infusion safety.
-
Explores how air bubble formation during medication preparation contributes to protein agitation, denaturation, and aggregation in biologics, and how I2F’s controlled air equilibrium may help reduce bubble-related stress at the point of vial access.
-
Examines infusion-related contributors to IVIG-associated aseptic meningitis, including pressure instability and microbubble introduction, and discusses how improved air management during preparation may support safer infusion practices.
-
Reviews potential mechanisms behind infusion-related hypersensitivity reactions in immunoglobulin therapy and evaluates how minimizing air introduction and pressure variability during vial access may improve medication tolerability.
-
This white paper explores how controlled air equilibrium during infusion preparation may support payer priorities by:
Helping preserve high-cost biologic medications by reducing foaming and handling-related losses
Improving preparation efficiency and nursing workflow during multi-vial infusions
Supporting more consistent medication handling practices across infusion sites
Enabling potential cost savings through improved operational efficiency and reduced medication loss
Aligning drug delivery practices with goals of cost containment, efficiency, and quality of care
-
Examines growing evidence of microplastic exposure from plastic-based medical delivery systems and introduces stainless steel vial access as a potential pathway to reduce particulate burden during injectable and infusion workflows.
Let’s Connect
We typically respond within 1 business day.